Trius Confident After Phase II Results Against Skin Infections That Include MRSA

Torezolid, a second generation oxazolidinone antibiotic, is set to enter Phase III trials in early 2010 with unambiguous regulatory guidance, CEO says.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet